Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Shares Outstanding (Entity) of $50.5 million for Q4 2025, up 9.64% year-on-year from $46.1 million in Q4 2024, and up 3.58% on a QoQ basis from $48.8 million in Q2 2025.

Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Shares Outstanding (Entity) for 6 consecutive years, with $50.5 million the latest figure, recorded in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 9.64% year-over-year to $50.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.5 million (up 9.64% YoY) and the FY2025 annual result came in at $50.5 million, up 9.64% from the prior year.
  • Shares Outstanding (Entity) grew to $50.5 million in Q4 2025 per MOLN's latest filing, from $48.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for MOLN reached as high as $50.5 million in Q4 2025 and fell as low as $32.6 million in Q2 2021.
  • A 5-year average of $40.6 million and a median of $40.5 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) grew 0.39% — and 2025, when it climbed 20.23%.
  • Year by year, Shares Outstanding (Entity) stood at $35.0 million in 2021, then rose by 6.84% to $37.4 million in 2022, then rose by 9.54% to $41.0 million in 2023, then gained by 12.42% to $46.1 million in 2024, then grew by 9.64% to $50.5 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $50.5 million, $48.8 million, and $46.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6,012.74 Bn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 47.82 Bn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.44 Bn
4 NuCana 279.75 Bn 279.75 Bn - 11.23 Bn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 400.00 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 62.19 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Molecular Partners Ag 147.97 Mn 147.97 Mn - 37.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.27 Mn
Dec 31, 2025 37.27 Mn
Sep 30, 2025 37.39 Mn
Jun 30, 2025 37.39 Mn
Mar 31, 2025 34.03 Mn
Dec 31, 2024 34.03 Mn
Sep 30, 2024 33.18 Mn
Jun 30, 2024 33.18 Mn
Mar 31, 2024 32.77 Mn
Dec 31, 2023 32.77 Mn
Sep 30, 2023 32.83 Mn
Jun 30, 2023 32.83 Mn
Mar 31, 2023 32.47 Mn
Dec 31, 2022 32.47 Mn
Sep 30, 2022 32.50 Mn
Jun 30, 2022 32.50 Mn
Mar 31, 2022 31.01 Mn
Dec 31, 2021 31.01 Mn
Sep 30, 2021 29.71 Mn
Jun 30, 2021 29.71 Mn